The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial

A Proposed Classification of the Immunological Diseases

Dennis McGonagle, Michael McDermott · PLoS Medicine · 2006 · 797 citations · Full text

Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis

David Saadoun, Michèlle Rosenzwajg, Florence Joly et al. · New England Journal of Medicine · 2011 · 728 citations · Full text

Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

Michèlle Rosenzwajg, Roberta Lorenzon, P. Cacoub et al. · Annals of the Rheumatic Diseases · 2018 · 383 citations · Full text

Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

Caroline von Spee-Mayer, Elise Siegert, Dimas Abdirama et al. · Annals of the Rheumatic Diseases · 2015 · 325 citations

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial

Jing He, Ruijun Zhang, Miao Shao et al. · Annals of the Rheumatic Diseases · 2019 · 317 citations · Full text